CN101066477B - 能在体捕获内皮祖细胞的生物人工血管 - Google Patents
能在体捕获内皮祖细胞的生物人工血管 Download PDFInfo
- Publication number
- CN101066477B CN101066477B CN2007100784822A CN200710078482A CN101066477B CN 101066477 B CN101066477 B CN 101066477B CN 2007100784822 A CN2007100784822 A CN 2007100784822A CN 200710078482 A CN200710078482 A CN 200710078482A CN 101066477 B CN101066477 B CN 101066477B
- Authority
- CN
- China
- Prior art keywords
- blood vessel
- endothelial
- cell
- collagen
- growth factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004204 blood vessel Anatomy 0.000 title claims abstract description 161
- 230000003511 endothelial effect Effects 0.000 title claims abstract description 79
- 239000002473 artificial blood Substances 0.000 title claims abstract description 76
- 238000001727 in vivo Methods 0.000 title abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 42
- 210000004027 cell Anatomy 0.000 claims abstract description 38
- 210000000329 smooth muscle myocyte Anatomy 0.000 claims abstract description 22
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 239000000427 antigen Substances 0.000 claims abstract description 9
- 108091007433 antigens Proteins 0.000 claims abstract description 9
- 102000036639 antigens Human genes 0.000 claims abstract description 9
- 210000001519 tissue Anatomy 0.000 claims abstract description 8
- 239000002131 composite material Substances 0.000 claims abstract description 5
- 210000002889 endothelial cell Anatomy 0.000 claims abstract description 3
- 210000000130 stem cell Anatomy 0.000 claims description 62
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims description 52
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 claims description 52
- 238000000034 method Methods 0.000 claims description 36
- 108010035532 Collagen Proteins 0.000 claims description 32
- 102000008186 Collagen Human genes 0.000 claims description 32
- 229920001436 collagen Polymers 0.000 claims description 32
- 230000002792 vascular Effects 0.000 claims description 28
- 239000013536 elastomeric material Substances 0.000 claims description 24
- 208000007536 Thrombosis Diseases 0.000 claims description 21
- 108010085895 Laminin Proteins 0.000 claims description 19
- 229920001661 Chitosan Polymers 0.000 claims description 16
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 12
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 12
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims description 12
- 101710088580 Stromal cell-derived factor 1 Proteins 0.000 claims description 12
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 claims description 12
- 230000005611 electricity Effects 0.000 claims description 12
- 210000003725 endotheliocyte Anatomy 0.000 claims description 12
- 239000003102 growth factor Substances 0.000 claims description 12
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 12
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 12
- 238000009987 spinning Methods 0.000 claims description 12
- 238000009941 weaving Methods 0.000 claims description 12
- 102000016942 Elastin Human genes 0.000 claims description 10
- 108010014258 Elastin Proteins 0.000 claims description 10
- 108010022355 Fibroins Proteins 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 229920002549 elastin Polymers 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000004626 polylactic acid Substances 0.000 claims description 9
- 239000002861 polymer material Substances 0.000 claims description 9
- 229920002994 synthetic fiber Polymers 0.000 claims description 9
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 claims description 8
- 102000019034 Chemokines Human genes 0.000 claims description 6
- 108010012236 Chemokines Proteins 0.000 claims description 6
- 102100037362 Fibronectin Human genes 0.000 claims description 6
- 108010067306 Fibronectins Proteins 0.000 claims description 6
- 102000009618 Transforming Growth Factors Human genes 0.000 claims description 6
- 108010009583 Transforming Growth Factors Proteins 0.000 claims description 6
- 230000015556 catabolic process Effects 0.000 claims description 6
- 238000004132 cross linking Methods 0.000 claims description 6
- 238000006731 degradation reaction Methods 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 5
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 230000003115 biocidal effect Effects 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 108010019407 glycyl-arginyl-glycyl-aspartic acid Proteins 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 210000005167 vascular cell Anatomy 0.000 claims description 4
- 229920000954 Polyglycolide Polymers 0.000 claims description 3
- 238000000502 dialysis Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 229950000845 politef Drugs 0.000 claims description 3
- 239000004633 polyglycolic acid Substances 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004882 Lipase Human genes 0.000 claims description 2
- 108090001060 Lipase Proteins 0.000 claims description 2
- 239000004367 Lipase Substances 0.000 claims description 2
- 102000057297 Pepsin A Human genes 0.000 claims description 2
- 108090000284 Pepsin A Proteins 0.000 claims description 2
- 102000004142 Trypsin Human genes 0.000 claims description 2
- 108090000631 Trypsin Proteins 0.000 claims description 2
- 238000009455 aseptic packaging Methods 0.000 claims description 2
- 230000009849 deactivation Effects 0.000 claims description 2
- 230000004069 differentiation Effects 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 claims description 2
- 238000011010 flushing procedure Methods 0.000 claims description 2
- 238000011534 incubation Methods 0.000 claims description 2
- 235000019421 lipase Nutrition 0.000 claims description 2
- 238000012423 maintenance Methods 0.000 claims description 2
- 238000000520 microinjection Methods 0.000 claims description 2
- 238000010899 nucleation Methods 0.000 claims description 2
- 230000003204 osmotic effect Effects 0.000 claims description 2
- 229940111202 pepsin Drugs 0.000 claims description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 2
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 210000004872 soft tissue Anatomy 0.000 claims description 2
- 239000012588 trypsin Substances 0.000 claims description 2
- 210000004231 tunica media Anatomy 0.000 claims description 2
- 230000004048 modification Effects 0.000 abstract description 5
- 238000012986 modification Methods 0.000 abstract description 5
- 230000002429 anti-coagulating effect Effects 0.000 abstract description 3
- 230000001575 pathological effect Effects 0.000 abstract description 2
- 230000000903 blocking effect Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- 239000003146 anticoagulant agent Substances 0.000 description 11
- 229940127219 anticoagulant drug Drugs 0.000 description 9
- 230000004087 circulation Effects 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 239000005482 chemotactic factor Substances 0.000 description 6
- 210000003038 endothelium Anatomy 0.000 description 6
- 206010020718 hyperplasia Diseases 0.000 description 6
- 230000007774 longterm Effects 0.000 description 5
- 241000294142 Vascellum Species 0.000 description 4
- 239000012237 artificial material Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 201000006828 endometrial hyperplasia Diseases 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 238000001215 fluorescent labelling Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 210000002955 secretory cell Anatomy 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 208000024248 Vascular System injury Diseases 0.000 description 3
- 208000012339 Vascular injury Diseases 0.000 description 3
- 206010053648 Vascular occlusion Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000009954 braiding Methods 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003090 iliac artery Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000000877 morphologic effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 208000021331 vascular occlusion disease Diseases 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000002706 hydrostatic effect Effects 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 208000037803 restenosis Diseases 0.000 description 2
- 210000003684 theca cell Anatomy 0.000 description 2
- 210000004026 tunica intima Anatomy 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 241001232809 Chorista Species 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 229920004933 Terylene® Polymers 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 206010072810 Vascular wall hypertrophy Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000005859 cell recognition Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000034373 developmental growth involved in morphogenesis Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002406 microsurgery Methods 0.000 description 1
- 244000309715 mini pig Species 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 238000011580 nude mouse model Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000012667 polymer degradation Methods 0.000 description 1
- -1 polytetrafluoroethylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000003752 saphenous vein Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000004901 spalling Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- 230000007556 vascular defect Effects 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100784822A CN101066477B (zh) | 2007-05-17 | 2007-05-17 | 能在体捕获内皮祖细胞的生物人工血管 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100784822A CN101066477B (zh) | 2007-05-17 | 2007-05-17 | 能在体捕获内皮祖细胞的生物人工血管 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101066477A CN101066477A (zh) | 2007-11-07 |
CN101066477B true CN101066477B (zh) | 2010-10-06 |
Family
ID=38879258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100784822A Active CN101066477B (zh) | 2007-05-17 | 2007-05-17 | 能在体捕获内皮祖细胞的生物人工血管 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101066477B (zh) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX350338B (es) | 2005-08-26 | 2017-09-04 | Univ Minnesota | Descelularizacion y recelularizacion de organos y tejidos. |
CN101357241B (zh) * | 2008-09-12 | 2012-06-13 | 西南交通大学 | 一种钛及其合金心血管植入装置的表面定向固定cd34抗体或cd133抗体的方法 |
CN101695587B (zh) * | 2009-10-21 | 2012-08-29 | 上海中山医疗科技发展公司 | 一种基因修饰及调控的内皮祖细胞捕获支架的制备方法 |
CN101766837B (zh) * | 2009-12-28 | 2013-03-27 | 中国人民解放军第二炮兵总医院 | 仿生多孔微球组织工程支架及其制作方法 |
SG188369A1 (en) | 2010-09-01 | 2013-04-30 | Univ Minnesota | Methods of recellularizing a tissue or organ for improved transplantability |
CN102648988A (zh) * | 2011-02-28 | 2012-08-29 | 刘斌 | Cd34抗体包被支架的制备方法 |
US9290738B2 (en) | 2012-06-13 | 2016-03-22 | Miromatrix Medical Inc. | Methods of decellularizing bone |
WO2014151739A1 (en) | 2013-03-15 | 2014-09-25 | Miromatrix Medical Inc. | Use of perfusion decellularized liver for islet cell recellularization |
EP2999494B1 (en) * | 2013-05-20 | 2020-09-16 | Yale University | Anti-thrombogenic grafts |
CN103509107B (zh) * | 2013-08-07 | 2015-02-25 | 浙江大学 | 利用特征多肽制备家蚕丝素蛋白特异抗体的方法 |
CN103509108B (zh) * | 2013-08-07 | 2015-02-25 | 浙江大学 | 利用特征十二多肽制备家蚕丝素蛋白特异抗体的方法 |
CN104826164B (zh) * | 2015-04-24 | 2018-05-22 | 广州宏畅生物科技有限公司 | 能在体实现自我重塑的生物人工血管 |
CN104771783A (zh) * | 2015-04-29 | 2015-07-15 | 广州宏畅生物科技有限公司 | 一种抗血栓形成和内膜增生的小口径生物人工血管 |
CN106139245A (zh) * | 2016-08-17 | 2016-11-23 | 林春梅 | 一种增强可降解血管支架材料及其制备方法 |
EP3509651B1 (en) | 2016-09-06 | 2022-12-28 | Miromatrix Medical Inc. | Use of resected liver serum for whole liver engineering |
CN107446818B (zh) * | 2016-09-14 | 2021-05-07 | 四川蓝光英诺生物科技股份有限公司 | 管腔组织构建体的打印装置、打印方法及管腔组织构建体 |
CN107456296B (zh) * | 2016-09-14 | 2020-07-14 | 四川蓝光英诺生物科技股份有限公司 | 管腔组织构建体、管腔组织构建体的制备方法及制备装置 |
CN107411845A (zh) * | 2016-09-14 | 2017-12-01 | 四川蓝光英诺生物科技股份有限公司 | 管腔组织构建体、管腔组织构建体制备方法及其装置 |
CN107496991B (zh) * | 2017-08-17 | 2020-09-25 | 邱雪峰 | 一种使人造血管的持久保持通畅的试剂盒和方法 |
CN108761080A (zh) * | 2018-08-16 | 2018-11-06 | 中国科学院合肥物质科学研究院 | 一个在体的特定细胞捕获盒 |
CN110038162B (zh) * | 2019-04-16 | 2021-08-31 | 苏州大学 | 一种具有调控血管细胞生长作用的功能丝素材料及其制备方法 |
CN110151791B (zh) * | 2019-05-24 | 2020-11-27 | 北京清华长庚医院 | 内皮祖细胞在移植治疗大鼠冠状动脉微栓塞中的应用 |
CN113440652A (zh) * | 2020-03-26 | 2021-09-28 | 中国科学院深圳先进技术研究院 | 人工血管及其制备方法 |
CN111544658B (zh) * | 2020-06-24 | 2022-02-01 | 中国人民解放军陆军军医大学 | 一种调控免疫反应和促进内膜再生的心血管植入物及其制备方法 |
-
2007
- 2007-05-17 CN CN2007100784822A patent/CN101066477B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101066477A (zh) | 2007-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101066477B (zh) | 能在体捕获内皮祖细胞的生物人工血管 | |
Campbell et al. | Development of tissue engineered vascular grafts | |
Seifalian et al. | Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering | |
US6197296B1 (en) | Tissue equivalents | |
Shum-Tim et al. | Tissue engineering of autologous aorta using a new biodegradable polymer | |
US5855610A (en) | Engineering of strong, pliable tissues | |
Thomas et al. | Advances in vascular tissue engineering | |
Shaikh et al. | Fibrin: a natural biodegradable scaffold in vascular tissue engineering | |
EP0299010B1 (en) | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices | |
US5759830A (en) | Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo | |
CN102076366B (zh) | 组织工程血管 | |
CN111714706B (zh) | 可促进血管细胞增殖和分泌细胞外基质的血管支架、血管支架的制备方法及活性人工血管 | |
JP2003062062A (ja) | インプラントおよびその製造方法 | |
Lepidi et al. | In vivo regeneration of small‐diameter (2 mm) arteries using a polymer scaffold | |
CA2346841A1 (en) | Cardiovascular components for transplantation and methods of making thereof | |
CN101690829B (zh) | 一种可再细胞化的生物瓣瓣膜材料的制备方法 | |
Łos et al. | Successful biomaterial-based artificial organ—updates on artificial blood vessels | |
CN1251769C (zh) | 基因修饰的组织工程血管 | |
CN100340220C (zh) | 一种在人工血管内表面种植内皮/内皮样细胞的方法 | |
CN110755174B (zh) | 一种生物混合型人工血管及其制备方法 | |
Menu et al. | Toward completely constructed and cellularized blood vessels | |
Pingchuan Zhang et al. | Collagen biomaterials for cardiac tissue engineering applications | |
Pontini et al. | Bioengineering of Vascular Conduits | |
JPH01170466A (ja) | 生体内インプラント材料 | |
CN116712612A (zh) | 一种具有微环境调节功能的组织工程仿生气管支架及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU HONGCHANG BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: NO.3 ARMY MEDICAL UNIV., PLA Effective date: 20111021 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 400038 SHAPINGBA, CHONGQING TO: 510545 GUANGZHOU, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20111021 Address after: 510545 Guangdong province high tech Industrial Development Zone of Guangzhou Science City skim Springs Road No. 3, Guangzhou international business incubator D, room 410, Room 411 Patentee after: GUANGZHOU HONGCHANG BIOTECHNOLOGY Co.,Ltd. Address before: Chongqing city Shapingba street 400038 gaotanyan No. 30 Patentee before: THIRD MILITARY MEDICAL University |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 510545, Guangzhou International Biological Island, Guangdong, four spiral Road, No. 1 production zone, second, 201 units Patentee after: GUANGZHOU HONGCHANG BIOTECHNOLOGY Co.,Ltd. Address before: 510545 Guangdong province high tech Industrial Development Zone of Guangzhou Science City skim Springs Road No. 3, Guangzhou international business incubator D, room 410, Room 411 Patentee before: GUANGZHOU HONGCHANG BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20231225 Address after: 400000 room 08, third floor, building 19, international maker port Park, No. 130, xiazhongdukou, Shapingba District, Chongqing Patentee after: Chongqing jiukang Medical Research Institute Co.,Ltd. Address before: 510545 unit 201, 2nd floor, production area, No.1 helix 4th Road, International Biological Island, Guangzhou City, Guangdong Province Patentee before: GUANGZHOU HONGCHANG BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |